Abstract
Hepatocellular carcinoma is one of the fastest growing cancers in the US and has a low survival rate, partly due to difficulties in early detection. Because of HCC's high heterogeneity, it has been suggested that multiple biomarkers would be needed to develop a sensitive HCC screening test. This study applied random forest (RF), a machine learning technique, and proposed two novel models, fixed sequential (FS) and two-step (TS), for comparison with two commonly used statistical techniques, logistic regression (LR) and classification and regression trees (CART), in combining multiple urine DNA biomarkers for HCC screening using biomarker values obtained from 137 HCC and 431 non-HCC (224 hepatitis and 207 cirrhosis) subjects. The sensitivity, specificity, area under the receiver operating curve, and variability were estimated through repeated 10-fold cross-validation to compare the models' performances in accuracy and robustness. We show that RF and TS have higher accuracy and stability; specifically, they reach 90% specificity and 86%/87% sensitivity respectively along with 15% higher sensitivity and 10% higher specificity than LR in cross-validation. The potential of RF and TS to develop a panel of multiple biomarkers and the p...Continue Reading
References
Sep 12, 2003·Bioinformatics·Baolin WuHongyu Zhao
Oct 28, 2004·Gastroenterology·Bruno DanieleVincenza Tinessa
Aug 13, 2005·Bioinformatics·Tobias SingThomas Lengauer
Dec 14, 2005·Biostatistics·Torsten HothornMark J van der Laan
Jul 1, 2006·Bioinformatics·Herbert PangHongyu Zhao
Jan 27, 2007·BMC Bioinformatics·Carolin StroblTorsten Hothorn
Feb 24, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hu-Liang JiaXin Wei Wang
Feb 5, 2008·Cancer Research·Bharathi LaxmanArul M Chinnaiyan
Jul 16, 2008·BMC Bioinformatics·Carolin StroblAchim Zeileis
May 21, 2009·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Mengjun WangAnand S Mehta
Dec 9, 2010·The Oncologist·Arun J SanyalRiccardo Lencioni
Mar 5, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jordi BruixUNKNOWN American Association for the Study of Liver Diseases
Jul 6, 2011·The Journal of Molecular Diagnostics : JMD·Selena Y LinYing-Hsiu Su
Apr 27, 2012·PloS One·Surbhi JainYing-Hsiu Su
Apr 28, 2012·Gastroenterology·Hashem B El-Serag
Feb 9, 2013·New Biotechnology·Cigdem OzenMehmet Ozturk
Apr 11, 2013·Expert Review of Molecular Diagnostics·Surbhi JainYing-Hsiu Su
Sep 3, 2013·Journal of Hepatology·Jean-Charles Nault, Jessica Zucman-Rossi
Aug 8, 2014·Expert Review of Molecular Diagnostics·Ying-Hsiu SuSurbhi Jain
Sep 16, 2014·International Journal of Cancer. Journal International Du Cancer·Jacques FerlayFreddie Bray
Nov 11, 2014·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Surbhi JainYing-Hsiu Su
Mar 10, 2015·Computational and Structural Biotechnology Journal·Konstantina KourouDimitrios I Fotiadis
Nov 8, 2016·BioMed Research International·Hilal Kazan
Aug 11, 2017·Hepatoma Research·Hie-Won HannYing-Hsiu Su
Citations
Apr 16, 2019·Genetic Testing and Molecular Biomarkers·Ying-Hsiu Su
Jan 7, 2020·British Journal of Biomedical Science·A M AttallahS O Abdallah
Jul 17, 2020·Frontiers in Neurology·Jean-Baptiste OudartRachid Mahmoudi
Mar 2, 2019·Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine·Kenta IshiiTetsuya Matsuoka
Sep 4, 2020·Scientific Reports·Srinivasulu Yerukala Sathipati, Shinn-Ying Ho
May 11, 2021·Health Information Science and Systems·Alan Baronio MenegottoSilvio Cesar Cazella